feed,title,long_url,short_url
gNews,Chardan Capital Reiterates Buy Rating for Intellia Therapeutics (NASDAQ:NTLA) - MarketBeat,https://www.marketbeat.com/instant-alerts/nasdaq-ntla-a-buy-or-sell-right-now-2022-09-2/,https://bit.ly/3BqT46U
